Normal variants in [18F]-fluorodeoxyglucose PET imaging

Radiologic Clinics of North America

Volumn 42, Issue 6, 2004, Pages 1063-1081

  El Haddad, Ghassan ^a   Alavi, Abass ^a   Mavi, Ayse ^a   Bural, Gonca ^a   Zhuang, Hongming ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; FLUORODEOXYGLUCOSE F 18; TRACER; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADIPOSE TISSUE; ARTICLE; ATTENUATION; BONE MARROW; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DIGESTIVE SYSTEM CANCER; DRUG DISTRIBUTION; DRUG UPTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEAD AND NECK CANCER; HUMAN; LIVER CANCER; MUSCLE TONE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SKELETAL MUSCLE; THORAX; THYMUS HYPERPLASIA; URINARY TRACT TUMOR; AGING; DECISION MAKING; IMAGE ENHANCEMENT; METABOLISM; METHODOLOGY; REVIEW; TISSUE DISTRIBUTION;

AGING; DECISION MAKING; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 5444249955     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2004.07.003     Document Type: Review

References (74)

1. A. Alavi, J.W. Kung, and H. Zhuang Implications of PET based molecular imaging on the current and future practice of medicine Semin Nucl Med 34 2004 56 69
2. D. Delbeke, and W.H. Martin Positron emission tomography imaging in oncology Radiol Clin North Am 39 2001 883 917
3. R.A. Hawkins, Y. Choi, S.C. Huang, C. Messa, C.K. Hoh, and M.E. Phelps Quantitating tumor glucose metabolism with FDG and PET J Nucl Med 33 1992 339 344
4. T. Torizuka, N. Tamaki, T. Inokuma, Y. Magata, S. Sasayama, and Y. Yonekura In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET J Nucl Med 36 1995 1811 1817
5. O. Warburg The metabolism of tumors 1930 Arnold Constable London
6. O. Warburg On the origin of cancer cells Science 123 1956 309 314
7. N. Avril, M. Menzel, J. Dose, M. Schelling, W. Weber, and F. Janicke Glucose metabolism of breast cancer assessed by F-18-FDG PET: histologic and immunohistochemical tissue analysis J Nucl Med 42 2001 9 16
8. R. Bos, J. van Der Hoeven, E. van Der Wall, P. van Der Groep, P. van Diest, and E. Comans Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography J Clin Oncol 20 2002 379 387
9. M.A. Khan, C.S. Combs, E.M. Brunt, V.J. Lowe, M.K. Wolverson, and H. Solomon Positron emission tomography scanning in the evaluation of hepatocellular carcinoma J Hepatol 32 2000 792 797
10. S. Barrington, and M. O'Doherty Limitations of PET for imaging lymphoma Eur J Nucl Med Mol Imaging 30 2003 S117 S127
11. H. Zhuang, and A. Alavi 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation Semin Nucl Med 32 2002 47 59
12. S. Yamada, K. Kubota, R. Kubota, T. Ido, and N. Tamahashi High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue J Nucl Med 36 1995 1301 1306
13. R.L. Wahl, C.A. Henry, and S.P. Ethier Serum glucose: efects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma Radiology 183 1992 643 647
14. T. Torizuka, A.C. Clavo, and R.L. Wahl Effect of hyperglycemia on in vitro tumor uptake of tritiated FDG, thymidine, L-methionine and L-leucine J Nucl Med 38 1997 382 386
15. G.J. Cook, I. Fogelman, and M.N. Maisey Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation Semin Nucl Med 26 1996 308 314
16. A. Guyton, and J. Hall Cerebral blood flow, the cerebrospinal fluid, and brain metabolism A.C. Guyten J.E. Hall Textbook of medical physiology 10th edition 2001 WB Saunders Philadelphia 714
17. D.E. Kuhl, E.J. Metter, W.H. Riege, and R.A. Hawkins The effect of normal aging on patterns of local cerebral glucose utilization Ann Neurol 15 1984 S133 S137
18. J. Chawluk, A. Alavi, R. Dann, H. Hurtig, S. Bais, and M. Kushner Positron emission tomography in aging and dementia: effect of cerebral atrophy J Nucl Med 28 1987 431 437
19. R. Mielke, J. Kessler, B. Szelies, K. Herholz, K. Wienhard, and W. Heiss Normal and pathological aging: findings of positron-emission-tomography J Neural Transm 105 1998 821 837
20. A. Loessner, A. Alavi, K.U. Lewandrowski, D. Mozley, E. Souder, and R.E. Gur Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age J Nucl Med 36 1995 1141 1149
21. M.P.M. Stokkel, V. Bongers, G.J. Hordijk, and P.P. Van Rijk FDG positron emission tomography in head and neck cancer: pitfall or pathology? Clin Nucl Med 24 1999 950 954
22. B.A. Jabour, Y. Choi, C.K. Hoh, S.D. Rege, J.C. Soong, and R.B. Lufkin Extracranial head and neck - pet imaging with 2- F-18 fluoro-2-deoxy-D-glucose and MR imaging correlation Radiology 186 1993 27 35
23. E. Kamel, G. Goerres, C. Burger, G. von Schulthess, and H. Steinert Recurrent laryngeal nerve palsy in patients with lung cancer: detection with PET-CT image fusion: report of six cases Radiology 224 2002 153 156
24. L. Kostakoglu, J. Wong, S. Barrington, B. Cronin, A. Dynes, and M. Maisey Speech-related visualization of laryngeal muscles with fluorine-18-FDG J Nucl Med 37 1996 1771 1773
25. G.W. Goerres, G.K. von Schulthess, and T.F. Hany Positron emission tomography and PET CT of the head and neck: FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment AJR Am J Roentgenol 179 2002 1337 1343
26. L.G. Strauss Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients Eur J Nucl Med 23 1996 1409 1415
27. T.F. Hany, E. Gharehpapagh, E.M. Kamel, A. Buck, J. Himms-Hagen, and G.K. von Schulthess Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region Eur J Nucl Med Mol Imaging 29 2002 1393 1398
28. C. Cohade, K. Mourtzikos, and R. Wahl USA-Fat: prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET/CT J Nucl Med 44 2003 1267 1270
29. H.W.D. Yeung, R.K. Grewal, M. Gonen, H. Schoder, and S.M. Larson Patterns of F-18-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET J Nucl Med 44 2003 1789 1796
30. S. Barrington, and M. Maisey Skeletal muscle uptake of fluorine-18-FDG: effect of oral diazepam J Nucl Med 37 1996 1127 1129
31. S. Yasuda, A. Shohtsu, M. Ide, S. Takagi, Y. Suzuki, and T. Tajima Diffuse F-18 FDG uptake in chronic thyroiditis Clin Nucl Med 22 1997 341
32. J. Santiago, S. Jana, H. El-Zeftawy, S. Naddaf, and H. Abdel-Dayem Increased F-18 fluorodeoxyglucose thyroidal uptake in Graves' disease Clin Nucl Med 24 1999 714 715
33. M.S. Cohen, N. Arslan, F. Dehdashti, G.M. Doherty, T.C. Lairmore, and L.M. Brunt Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography Surgery 130 2001 941 946
34. Y. Choi, R.C. Brunken, R.A. Hawkins, S.C. Huang, D.B. Buxton, and C.K. Hoh Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans Eur J Nucl Med 20 1993 308 318
35. M. Diksic, K. Sako, W. Feindel, A. Kato, Y.L. Yamamoto, and S. Farrokhzad Pharmacokinetics of positron-labeled 1,3-bis(2-chloroethyl)nitrosourea in human brain tumors using positron emission tomography Cancer Res 44 1984 3120 3124
36. A. Alavi, N. Gupta, J.L. Alberini, M. Hickeson, L.E. Adam, and P. Bhargava Positron emission tomography imaging in nonmalignant thoracic disorders Semin Nucl Med 32 2002 293 321
37. A. Steinmetz, M. Maisey, and R. Hardoff Patterns of papillary muscle ischemia in myocardial PET Clin Nucl Med 29 2004 1 4
38. T. Nakahara, H. Fujii, M. Ide, N. Nishiumi, W. Takahashi, and S. Yasuda FDG uptake in the morphologically normal thymus: comparison of FDG positron emission tomography and CT Br J Radiol 74 2001 821 824
39. I. Brink, M. Reinhardt, S. Hoegerle, C. Altehoefer, E. Moser, and E. Nitzsche Increased metabolic activity in the thymus gland studied with 18F-FDG PET: age dependency and frequency after chemotherapy J Nucl Med 42 2001 591 595
40. C. Wittram, A.J. Fischman, E. Mark, J. Ko, and J.A.O. Shepard Original report: thymic enlargement and FDG uptake in three patients: CT and FDG positron emission tomography correlated with pathology AJR Am J Roentgenol 180 2003 519 522
41. M. Bangerter, M. Griesshammer, J. Kotzerke, S.N. Reske, and L. Bergmann Positron emission tomography with 18-F-fluorodeoxyglucose in the staging and follow-up of lymphoma: status quo and quo vadis Onkologie 22 1999 382 386
42. H. Alibazoglu, B. Alibazoglu, E.F. Hollinger, S.A. Ingram, W.A. Willoughby, and G. LaMonica Normal thymic uptake of 2-deoxy-2[F-18]fluoro-D- glucose Clin Nucl Med 24 1999 597 600
43. F. Pagliai, L. Rigacci, V. Briganti, C. Dini, A. Castagnoli, and L. Vaggelli PET scan evaluation of thymic mass after autologous peripheral blood stem-cell transplantation in an adult with non-Hodgkin's lymphoma Leuk Lymphoma 44 2003 2015 2018
44. I. Ak, M.P.M. Stokkel, and E.K.J. Pauwels Positron emission tomography with 2-[F-18]fluoro-2-deoxy-D-glucose in oncology Part II. The clinical value in detecting and staging primary tumours J Cancer Res Clin Oncol 126 2000 560 574
45. D. Vranjesevic, C. Schiepers, D.H. Silverman, A. Quon, J. Villalpando, and M. Dahlbom Relationship between F-18-FDG uptake and breast density in women with normal breast tissue J Nucl Med 44 2003 1238 1242
46. R. Hicks, D. Binns, and M. Stabin Pattern of uptake and excretion of (18)F-FDG in the lactating breast J Nucl Med 42 2001 1238 1242
47. L. Kostakoglu, H. Agress, and S.J. Goldsmith Clinical role of FDG PET in evaluation of cancer patients Radiographics 23 2003 315 340
48. P.D. Shreve, Y. Anzai, and R.L. Wahl Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants Radiographics 19 1999 61 77
49. J. Kellow, T. Borody, S. Phillips, R. Tucker, and A. Haddad Human interdigestive motility: variations in patterns from esophagus to colon Gastroenterology 91 1986 386 395
50. H. Koga, M. Sasaki, Y. Kuwabara, K. Hiraka, M. Nakagawa, and K. Abe An analysis of the physiological FDG uptake pattern in the stomach Ann Nucl Med 17 2003 733 738
51. F. Miraldi, H. Vesselle, P.F. Faulhaber, L.P. Adler, and G.P. Leisure Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer Clin Nucl Med 23 1998 3 7
52. S. Kim, J. Chung, B. Kim, S. Kim, J. Jeong, and D. Lee Relationship between gastrointestinal F-18-fluorodeoxyglucose accumulation and gastrointestinal symptoms in whole-body PET Clin Positron Imaging 2 1999 273 279
53. A. Stahl, W.A. Weber, N. Avril, and M. Schwaiger Effect of N-butylscopolamine on intestinal uptake of fluorine-18-fluorodeoxyglucose in PET imaging of the abdomen Nuklearmedizin 39 2000 241 245
54. R. Tatlidil, H. Jadvar, J.R. Bading, and P.S. Conti Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings Radiology 224 2002 783 787
55. S. Yasuda, H. Fujii, T. Nakahara, N. Nishiumi, W. Takahashi, and M. Ide F-18-FDG PET detection of colonic adenomas J Nucl Med 42 2001 989 992
56. B.A. Gordon, F.L. Flanagan, and F. Dehdashti Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations AJR Am J Roentgenol 169 1997 1675 1680
57. H. Zhuang, M. Hickeson, T.K. Chacko, P.S. Duarte, K.Z. Nakhoda, and Q. Feng Incidental detection of colon cancer by FDG positron emission tomography in patients examined for pulmonary nodules Clin Nucl Med 27 2002 628 632
58. D. Eddy Screening for colorectal cancer Ann Intern Med 113 1990 373 384
59. Y. Sugawara, S.J. Fisher, K.R. Zasadny, P.V. Kison, L.H. Baker, and R.L. Wahl Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy J Clin Oncol 16 1998 173 180
60. S. Jones, A. Alavi, D. Christman, I. Montanez, A. Wolf, and M. Reivich The radiation dosimetry of 2 [F-18]fluoro-2-deoxy-D-glucose in man J Nucl Med 23 1982 613 617
61. H.J. Vesselle, and F.D. Miraldi FDG PET of the retroperitoneum: normal anatomy, variants, pathologic conditions, and strategies to avoid diagnostic pitfalls Radiographics 18 1998 805 823
62. H. Zhuang, A.J. Yamamoto, P. Sinha, M. Pourdehnad, and A. Alavi Similar pelvic abnormalities on FDG positron emission tomography of different origins Clin Nucl Med 26 2001 515 517
63. H. Lerman, U. Metser, D. Grisaru, A. Fishman, G. Lievshitz, and E. Even-Sapir Normal and abnormal F-18-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT J Nucl Med 45 2004 266 271
64. S. Kosuda, S. Fisher, P. Kison, R. Wahl, and H. Grossman Uptake of 2-deoxy-2-[18F]fluoro-D-glucose in the normal testis: retrospective PET study and animal experiment Ann Nucl Med 11 1997 195 199
65. C. Cohade, M. Osman, and R.L. Wahl The supraclavicular FDG "musclea" uptake artifact is often not muscle: evaluation with PET-CT [abstract] J Nucl Med 43 2002 113
66. D. Delbeke Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma J Nucl Med 40 1999 591 603
67. T. Higashi, S.J. Fisher, R.S. Brown, K. Nakada, G.L. Walter, and R.L. Wahl Evaluation of the early effect of local irradiation on normal rodent bone marrow metabolism using FDG: preclinical PET studies J Nucl Med 41 2000 2026 2035
68. H. Zhuang, J.W. Sam, T.K. Chacko, P.S. Duarte, M. Hickeson, and Q. Feng Rapid normalization of osseous FDG uptake following traumatic or surgical fractures Eur J Nucl Med Mol Imaging 30 2003 1096 1103
69. T.K. Chacho, H. Zhuang, K.Z. Nakhoda, B. Moussavian, and A. Alavi Application of fluorodeoxyglucose positron emission tomography in the diagnosis of infection Nucl Med Commun 24 2003 615 624
70. J.H.F. Rudd, E.A. Warburton, T.D. Fryer, H.A. Jones, J.C. Clark, and N. Antoun Imaging atherosclerotic plaque inflammation with F-18-fluorodeoxyglucose positron emission tomography Circulation 105 2002 2708 2711
71. M.J. Yun, D. Yeh, L.I. Araujo, S.Y. Jang, A. Newberg, and A. Alavi F-18FDG uptake in the large arteries: a new observation Clin Nucl Med 26 2001 314 319
72. M. Tatsumi, C. Cohade, Y. Nakamoto, and R.L. Wahl Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis Radiology 229 2003 831 837
73. S. Chiang, A. Rebenstock, L. Guan, J. Burns, A. Alavi, and H. Zhuang Potential false-positive FDG PET imaging caused by subcutaneous radiotracer infiltration Clin Nucl Med 28 2003 786 788
74. H. Zhuang, M.E. Cunnane, N.V. Ghesani, P.D. Mozley, and A. Alavi Chest tube insertion as a potential source of false-positive FDG-positron emission tomographic results Clin Nucl Med 27 2002 285 286